IP Verse

Viiv Healthcare patent opposition analysis

Get complete Patent Opposition Report for Viiv Healthcare

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest patents of Viiv Healthcare opposed by its competitors

Explore Viiv Healthcare's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3494972	Dec 13, 2023	Combinations Of Dolutegravir And Lamivudine For The Treaetment Of Hiv Infection	9
EP3045206	Feb 15, 2023	Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity	1
EP3284520	Jun 5, 2019	Polycyclic Carbamoylpyridone Derivative Having Hiv Integrase Inhibitory Activity	1
EP3127542	Aug 22, 2018	Antiviral Therapy	4
EP2932970	Mar 21, 2018	Antiviral Therapy	2

Top competitors of Viiv Healthcare

TEVA PHARMACEUTICAL INDUSTRIES

COOKE

GILEAD SCIENCES